NM_007198.4:c.260C>T

Variant summary

Our verdict is Pathogenic. The variant received 10 ACMG points: 10P and 0B. PM2PP5_Very_Strong

The NM_007198.4(PLPBP):​c.260C>T​(p.Pro87Leu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000634 in 1,609,148 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Likely pathogenic (★★).

Frequency

Genomes: 𝑓 0.000033 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000067 ( 0 hom. )

Consequence

PLPBP
NM_007198.4 missense

Scores

4
9
5

Clinical Significance

Pathogenic/Likely pathogenic criteria provided, multiple submitters, no conflicts P:4

Conservation

PhyloP100: 7.52

Publications

4 publications found
Variant links:
Genes affected
PLPBP (HGNC:9457): (pyridoxal phosphate binding protein) This gene encodes a pyridoxal 5'-phosphate binding protein involved in the homeostatic regulation of intracellular pyridoxal 5'-phosphate. This gene has a tumor suppressive effect on hepatocellular carcinoma and other solid tumors of epithelial origin. Naturally occurring mutations in this gene are associated with a pyridoxine-dependent epilepsy. [provided by RefSeq, Mar 2017]
PLPBP Gene-Disease associations (from GenCC):
  • epilepsy, early-onset, vitamin B6-dependent
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • pyridoxine-dependent epilepsy
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Pathogenic. The variant received 10 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 8-37766296-C-T is Pathogenic according to our data. Variant chr8-37766296-C-T is described in ClinVar as [Likely_pathogenic]. Clinvar id is 374856.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PLPBPNM_007198.4 linkc.260C>T p.Pro87Leu missense_variant Exon 4 of 8 ENST00000328195.8 NP_009129.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PLPBPENST00000328195.8 linkc.260C>T p.Pro87Leu missense_variant Exon 4 of 8 1 NM_007198.4 ENSP00000333551.3 O94903

Frequencies

GnomAD3 genomes
AF:
0.0000329
AC:
5
AN:
152100
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000483
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000441
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000202
AC:
5
AN:
247412
AF XY:
0.00000747
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000444
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000666
AC:
97
AN:
1457048
Hom.:
0
Cov.:
30
AF XY:
0.0000662
AC XY:
48
AN XY:
724842
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33086
American (AMR)
AF:
0.00
AC:
0
AN:
43858
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26050
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39396
South Asian (SAS)
AF:
0.00
AC:
0
AN:
85488
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53370
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5752
European-Non Finnish (NFE)
AF:
0.0000838
AC:
93
AN:
1109834
Other (OTH)
AF:
0.0000664
AC:
4
AN:
60214
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.449
Heterozygous variant carriers
0
4
8
12
16
20
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000329
AC:
5
AN:
152100
Hom.:
0
Cov.:
32
AF XY:
0.0000404
AC XY:
3
AN XY:
74280
show subpopulations
African (AFR)
AF:
0.0000483
AC:
2
AN:
41410
American (AMR)
AF:
0.00
AC:
0
AN:
15268
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5200
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4824
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10588
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.0000441
AC:
3
AN:
68020
Other (OTH)
AF:
0.00
AC:
0
AN:
2092
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.465
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000450
Hom.:
0
Bravo
AF:
0.0000227
TwinsUK
AF:
0.000270
AC:
1
ALSPAC
AF:
0.00
AC:
0
ExAC
AF:
0.0000165
AC:
2

ClinVar

Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Pathogenic:2
Oct 30, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces proline, which is neutral and non-polar, with leucine, which is neutral and non-polar, at codon 87 of the PROSC protein (p.Pro87Leu). This variant is present in population databases (rs755946598, gnomAD 0.008%). This missense change has been observed in individual(s) with clinical features of pyridoxine-dependent epilepsy (PMID: 27912044, 28391250, 29689137, 33766999). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 374856). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is not expected to disrupt PROSC protein function with a negative predictive value of 80%. Experimental studies are conflicting or provide insufficient evidence to determine the effect of this variant on PROSC function (PMID: 27912044, 29689137). For these reasons, this variant has been classified as Pathogenic. -

Sep 01, 2023
GeneDx
Significance:Likely pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 29689137, 28914444, 28391250, 27912044, 33766999, 33728241, 36007526, 33425341) -

Epilepsy, early-onset, vitamin B6-dependent Pathogenic:2
Jan 16, 2020
Rady Children's Institute for Genomic Medicine, Rady Children's Hospital San Diego
Significance:Likely pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant has been previously reported as compound heterozygous change and as homozygous change in patients with Epilepsy, early-onset, vitamin B6-dependent (PMID: 27912044, 28391250). Based on complementation studies in PROSC-deficient E. coli the p.Pro87Leu protein appeared to retained some function (PMID: 27912044). Additional functional studies in bacteria showed that the p.Pro87Leu variant results in decreased protein solubility (PMID: 29689137). It is present in the heterozygous state in the gnomAD population database at a frequency of 0.003% (7/278808) and is absent in the homozygous state, thus is presumed to be rare. In silico tools used to predict the effect of this variant on protein function yield discordant results. Based on the available evidence, the c.260C>T (p.Pro87Leu) variant is classified as Likely Pathogenic. -

Aug 14, 2023
OMIM
Significance:Pathogenic
Review Status:no assertion criteria provided
Collection Method:literature only

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.30
BayesDel_addAF
Pathogenic
0.17
D
BayesDel_noAF
Uncertain
0.070
CADD
Pathogenic
27
DANN
Uncertain
1.0
DEOGEN2
Benign
0.23
T;T;.;T
Eigen
Uncertain
0.30
Eigen_PC
Uncertain
0.43
FATHMM_MKL
Pathogenic
1.0
D
LIST_S2
Pathogenic
0.97
D;D;D;D
M_CAP
Benign
0.021
T
MetaRNN
Uncertain
0.65
D;D;D;D
MetaSVM
Benign
-0.84
T
PhyloP100
7.5
PrimateAI
Uncertain
0.70
T
PROVEAN
Pathogenic
-4.7
D;D;D;D
REVEL
Uncertain
0.35
Sift
Uncertain
0.024
D;D;D;D
Sift4G
Uncertain
0.057
T;T;T;D
Polyphen
0.041
B;.;.;.
Vest4
0.84
MutPred
0.59
Gain of sheet (P = 0.0049);Gain of sheet (P = 0.0049);.;.;
MVP
0.51
MPC
0.92
ClinPred
0.96
D
GERP RS
5.3
PromoterAI
0.0082
Neutral
Varity_R
0.64
gMVP
0.65
Mutation Taster
=17/83
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.030
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs755946598; hg19: chr8-37623814; API